The discovery of many different mechanisms working in neuronal and non-neuronal cells, at synapses, and in the cell body since the human gene FMR1 was identified [69] has highlighted that multiple pathways are affected in FXS. The gene discussed is FMR1; the disease is fragile X syndrome.